Shallcross Steven A has bought 14,000 shares of Theriva Biologics, Inc. [SYN] at $0.69 a share.
Theriva Biologics, Inc. [SYN] disclosed in an SEC Form 4 submission Wednesday, June 7, 2023 that the deal increased Shallcross Steven A's holding in the company to 250,000.
Theriva Biologics, Inc. [SYN] is a Pharmaceutical Preparations company based in Nevada.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.